SETD5-Coordinated Chromatin Reprogramming Regulates Adaptive Resistance to Targeted Pancreatic Cancer Therapy

Authors:

Abstract
No abstract available
Funding Information
  • Stanford University
  • University of Texas MD Anderson Cancer Center

This publication has 70 references indexed in Scilit: